glp-1 news november 2025 Side Effects: Endocrine Society Journals Look at GLP-1RAs and the Positive and Negative Unintended Impacts Wegovy maker Novo Nordisk makes

Nasogastric versus nasojejunal tube feeding for severe acute pancreatitis

La crioliplisis es segura, puede haber efectos secundarios como hemos nombrado con anterioridad, pero no son en ningn caso efectos secundarios elevados

MARK HYMAN: It's not easy, no

Underwriters are also getting better at detecting GLP-1 use through: Prescription databases Medical records requests Follow-up health questionnaires What This Means for Your Clients If currently on GLP-1 medications: Expect questions about medication use and duration Be prepared for potentially higher rates despite current health improvements Consider timing of application if they've been stable on medication for an extended period If recently stopped GLP-1 medications: Underwriters may view recent discontinuation as a risk factor Weight regain could further complicate the application process Medical follow-up showing sustained health improvements may help If planning to start GLP-1 medications: Understand that future applications may be affected by medication use Industry Trends to Watch Some forward-thinking insurance companies are exploring partnerships with GLP-1 providers to improve medication adherence